Semaglutide Clinical Trials in Weslaco, TX
As of July 2026, 1 paid clinical trial is testing Semaglutide in Weslaco, Texas. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Weslaco
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
2 clinical trials testing Semaglutide
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Top Research Study Locations in Weslaco
Researchers run research studies in Weslaco, TX at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Texas Valley Clinical Research | Obesity, Overweight, Diabetes Mellitus, Type 2 | 11 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 3 |
| Pulmonary and Sleep Center of the Valley | Myositis | 1 |
| Rio Grande Pain Team | Lumbar Spinal Stenosis | 1 |
| South Heart Clinic | Atrial Enlargement, Cardiotoxicity, Conduction Defect | 1 |
| Texas Oncology - Central/South Texas | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Texas Oncology - Weslaco | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 1 |
| Texas Oncology - Weslaco, Knapp Medical Plaza | Melanoma | 1 |
| Texas Oncology- Central South | Breast Cancer | 1 |
| Texas Valley Clinical Research, LLC | Cortisol Excess, Type 2 Diabetes | 1 |
| USOR - Texas Oncology | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
Active & Upcoming Studies in Weslaco (2026)
Recruiting trials in Weslaco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (10 active studies)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Cancer & tumors (8 active studies)
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Cardiovascular (3 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
Common conditions studied in Weslaco
- Obesity (5 active studies)
- Overweight (5 active studies)
- Breast Cancer (2 active studies)
- Diabetes Mellitus, Type 2 (2 active studies)
- Heart Failure (2 active studies)
- Type 2 Diabetes (2 active studies)
Leading research sponsors in Weslaco
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- AbbVie
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Weslaco?
There are approximately 25 recruiting clinical trials in Weslaco, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Weslaco pay participants?
Most recruiting trials in Weslaco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Weslaco?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Weslaco?
The most common conditions under active study in Weslaco include Obesity (5), Overweight (5), Breast Cancer (2), Diabetes Mellitus, Type 2 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Weslaco?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Weslaco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Weslaco?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Weslaco?
Recruiting research sites in Weslaco include Texas Valley Clinical Research, Texas Oncology - Central South, Pulmonary and Sleep Center of the Valley, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Weslaco right now?
The largest active categories in Weslaco are Diabetes & metabolic (10), Cancer & tumors (8), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.